DexCom Inc (DXCM.OQ)
DXCM.OQ on NASDAQ Stock Exchange Global Select Market
22.10USD
10:57am EDT
22.10USD
10:57am EDT
Price Change (% chg)
$0.32 (+1.47%)
$0.32 (+1.47%)
Prev Close
$21.78
$21.78
Open
$22.02
$22.02
Day's High
$22.31
$22.31
Day's Low
$22.02
$22.02
Volume
17,243
17,243
Avg. Vol
165,981
165,981
52-wk High
$24.35
$24.35
52-wk Low
$10.66
$10.66
About
DexCom, Inc. (DexCom) is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. The Company had received... (more)
Overall
| Beta: | 0.77 |
| Market Cap (Mil.): | $1,539.50 |
| Shares Outstanding (Mil.): | 70.68 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| DXCM.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 27.50 | 37.76 |
| EPS (TTM): | -0.75 | -- | -- |
| ROI: | -55.87 | 9.26 | 18.76 |
| ROE: | -59.53 | 12.54 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Roche Holding Ltd. (ROG.VX) | CHF228.00 | -3.50 |
| Johnson & Johnson (JNJ.N) | $93.91 | +0.41 |
| Abbott Laboratories (ABT.N) | $36.95 | +0.32 |
| Bayer AG (BAYGn.DE) | €89.06 | +1.71 |
| Bayer AG (BAYE.F) | -- | -- |
| Medtronic, Inc. (MDT.N) | $55.42 | +0.18 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Jefferson Research
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

